Nebius CRO sells 7,000 shares after option exercise
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
4
Rhea-AI Filing Summary
Nebius Group N.V. (NBIS) reported that Chief Revenue Officer Marc Boroditsky exercised options for a total of 7,000 Class A shares at an exercise price of $40.00 per share on September 14, 2026 and sold the same 7,000 shares that day in market transactions. The sales were made under a Rule 10b5-1 trading plan adopted on June 15, 2026, and the company notes its status as a foreign private issuer exempts these transactions from certain U.S. short-swing profit rules.
Insider Trade Summary 10b5-1
Exercise and Sale: 7,000 shares ($1.18M approx. pre-tax spread)
Exercise and Sale
6 txns
Insider
Boroditsky Marc
Role
Chief Revenue Officer
Sold
7,000 shs ($1.46M)
Approx. gross sale proceeds
$1.46M
Approx. exercise cost
$280K
Approx. pre-tax spread
$1.18M
Share of Position Sold
100%
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Stock Options F2 | 5,000 | $0.00 | $0.00 |
| Exercise | Stock Options F2 | 2,000 | $0.00 | $0.00 |
| Exercise | Class A Shares | 5,000 | $0.00 | $0.00 |
| Sale | Class A Shares F1 | 5,000 | $209.26 | $1.05M |
| Exercise | Class A Shares | 2,000 | $0.00 | $0.00 |
| Sale | Class A Shares F1 | 2,000 | $208.63 | $417K |
Holdings After Transaction:
Stock Options — 343,000 contracts (Direct);
Class A Shares — 0 shares (Direct)
Holdings Before and After:
Stock Options, 350,000 to 343,000 contracts (Direct);
Class A Shares, 0 to 0 shares (Direct)
Other Insiders: 3 other insiders reported open-market sales of this stock in the 30 days up to this filing.
Footnotes (2)
- F1. The sales reported on this Form 4 were made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on 15 June 2026.
- F2. The options vested in quarterly installments beginning on 31 May 2026.
Key Figures
Shares sold: 7,000 shares
Shares sold at $209.26: 5,000 shares
Shares sold at $208.63: 2,000 shares
+5 more
8 metrics
Shares sold
7,000 shares
Class A shares sold by Marc Boroditsky on September 14, 2026
Shares sold at $209.26
5,000 shares
Class A shares sold at $209.26 per share on September 14, 2026
Shares sold at $208.63
2,000 shares
Class A shares sold at $208.63 per share on September 14, 2026
Options exercised
7,000 underlying shares
Stock options exercised into Class A shares on September 14, 2026
Option exercise price
$40.00 per share
Exercise price of stock options covering Class A shares
Option expiration date
June 1, 2035
Expiration date of the exercised stock options
10b5-1 plan adoption date
June 15, 2026
Date the Rule 10b5-1 trading plan was adopted
Vesting start date
May 31, 2026
Options vested in quarterly installments beginning on this date
Key Terms
Rule 10b5-1 trading plan, foreign private issuer, Rule 3a12-3(b), Sections 16(b) and 16(c)
4 terms
Rule 10b5-1 trading plan regulatory
"The sales reported on this Form 4 were made pursuant to a Rule 10b5-1 trading plan"
A Rule 10b5-1 trading plan is a pre-arranged schedule that allows company insiders to buy or sell stock at specific times, even if they have inside information. It helps prevent accusations of unfair trading by making these transactions look planned and transparent, rather than sneaky or illegal.
foreign private issuer regulatory
"Due to the issuer's status as a foreign private issuer pursuant to Rule 3a12-3(b)"
A foreign private issuer is a company organized outside the United States that meets tests showing it is primarily foreign-controlled and therefore qualifies for a different set of U.S. reporting rules. For investors, that means the company files less frequent or differently formatted disclosures with U.S. regulators and may follow home-country accounting and governance practices, so buying its stock is like dining at a well-reviewed restaurant that follows its home kitchen’s rules instead of the local menu — you get access but should check what standards apply.
Rule 3a12-3(b) regulatory
"status as a foreign private issuer pursuant to Rule 3a12-3(b) under the Act"
Sections 16(b) and 16(c) regulatory
"equity securities are exempt from Sections 16(b) and 16(c) of the Act"
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did NBIS’s Chief Revenue Officer do in the latest Form 4?
Marc Boroditsky exercised options for 7,000 Class A shares at $40.00 per share and sold 7,000 Class A shares on September 14, 2026 in market transactions, as reported for Nebius Group N.V.
Were the NBIS insider sales made under a Rule 10b5-1 trading plan?
Yes. The filing states the sales “were made pursuant to a Rule 10b5-1 trading plan” adopted by Marc Boroditsky on June 15, 2026, indicating the trades were pre-arranged under that plan.
What options did the NBIS executive exercise in this Form 4?
Marc Boroditsky exercised stock options covering 7,000 Class A shares at an exercise price of $40.00 per share. The options began vesting in quarterly installments starting on May 31, 2026 and have an expiration date of June 1, 2035.
How is Nebius Group (NBIS) classified for U.S. securities law purposes?
Nebius Group N.V. is described as a foreign private issuer under Rule 3a12-3(b). Because of this status, the executive’s transactions are disclosed but are stated to be exempt from Sections 16(b) and 16(c) of the Securities Exchange Act.
AI-generated analysis. How Rhea-AI works. Not financial advice.
